PT Ekadharma International Tbk EBIT

PT Ekadharma International Tbk (EKAD.JK) currently reports a EBIT of $56B as of June 2026. That compares with $49B in the prior-year period — up 12.7% year over year. That is below the sector sector average of $2.5T. Use the charts on this page to explore PT Ekadharma International Tbk's EBIT history and peer comparisons.

PT Ekadharma International Tbk's EBIT increased from $49B to $56B — a 12.7% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PT Ekadharma International Tbk's EBIT of $56B is lower than the its sector sector average of $2.5T. That is roughly 97.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

PT Ekadharma International Tbk reported $56B in EBIT as of June 2026. That compares with $49B in the prior-year period — up 12.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $56B, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.5T. From there, open related valuation or income-statement pages for PT Ekadharma International Tbk, and consider following EKAD.JK for alerts when major investors trade the stock.